385 related articles for article (PubMed ID: 10523833)
1. cis-Determinants in the cytoplasmic domain of CEACAM1 responsible for its tumor inhibitory function.
Izzi L; Turbide C; Houde C; Kunath T; Beauchemin N
Oncogene; 1999 Sep; 18(40):5563-72. PubMed ID: 10523833
[TBL] [Abstract][Full Text] [Related]
2. Association of an 80 kDa protein with C-CAM1 cytoplasmic domain correlates with C-CAM1-mediated growth inhibition.
Luo W; Earley K; Tantingco V; Hixson DC; Liang TC; Lin SH
Oncogene; 1998 Mar; 16(9):1141-7. PubMed ID: 9528856
[TBL] [Abstract][Full Text] [Related]
3. Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells.
Beauchemin N; Kunath T; Robitaille J; Chow B; Turbide C; Daniels E; Veillette A
Oncogene; 1997 Feb; 14(7):783-90. PubMed ID: 9047385
[TBL] [Abstract][Full Text] [Related]
4. Role of CEACAM1 isoforms in an in vivo model of mammary morphogenesis: mutational analysis of the cytoplasmic domain of CEACAM1-4S reveals key residues involved in lumen formation.
Yokoyama S; Chen CJ; Nguyen T; Shively JE
Oncogene; 2007 Dec; 26(55):7637-46. PubMed ID: 17546042
[TBL] [Abstract][Full Text] [Related]
5. Optimal ratios of biliary glycoprotein isoforms required for inhibition of colonic tumor cell growth.
Turbide C; Kunath T; Daniels E; Beauchemin N
Cancer Res; 1997 Jul; 57(13):2781-8. PubMed ID: 9205090
[TBL] [Abstract][Full Text] [Related]
6. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
[TBL] [Abstract][Full Text] [Related]
7. The cytoplasmic domain of C-CAM1 tumor suppressor is necessary and sufficient for suppressing the tumorigenicity of prostate cancer cells.
Estrera VT; Luo W; Phan D; Earley K; Hixson DC; Lin SH
Biochem Biophys Res Commun; 1999 Oct; 263(3):797-803. PubMed ID: 10512760
[TBL] [Abstract][Full Text] [Related]
8. The tumor growth-inhibiting cell adhesion molecule CEACAM1 (C-CAM) is differently expressed in proliferating and quiescent epithelial cells and regulates cell proliferation.
Singer BB; Scheffrahn I; Obrink B
Cancer Res; 2000 Mar; 60(5):1236-44. PubMed ID: 10728682
[TBL] [Abstract][Full Text] [Related]
9. Identification of allelic variants of the bovine immune regulatory molecule CEACAM1 implies a pathogen-driven evolution.
Kammerer R; Popp T; Singer BB; Schlender J; Zimmermann W
Gene; 2004 Sep; 339():99-109. PubMed ID: 15363850
[TBL] [Abstract][Full Text] [Related]
10. Association of pp60c-src with biliary glycoprotein (CD66a), an adhesion molecule of the carcinoembryonic antigen family downregulated in colorectal carcinomas.
Brümmer J; Neumaier M; Göpfert C; Wagener C
Oncogene; 1995 Oct; 11(8):1649-55. PubMed ID: 7478590
[TBL] [Abstract][Full Text] [Related]
11. The CEACAM1-L Ser503 residue is crucial for inhibition of colon cancer cell tumorigenicity.
Fournès B; Sadekova S; Turbide C; Létourneau S; Beauchemin N
Oncogene; 2001 Jan; 20(2):219-30. PubMed ID: 11313949
[TBL] [Abstract][Full Text] [Related]
12. The cytoplasmic domain of CEACAM1-L controls its lateral localization and the organization of desmosomes in polarized epithelial cells.
Sundberg U; Beauchemin N; Obrink B
J Cell Sci; 2004 Mar; 117(Pt 7):1091-104. PubMed ID: 14970258
[TBL] [Abstract][Full Text] [Related]
13. Biliary glycoprotein (BGPa, CD66a, CEACAM1) mediates inhibitory signals.
Chen T; Zimmermann W; Parker J; Chen I; Maeda A; Bolland S
J Leukoc Biol; 2001 Aug; 70(2):335-40. PubMed ID: 11493628
[TBL] [Abstract][Full Text] [Related]
14. Suppression of tumorigenicity of breast cancer cells by an epithelial cell adhesion molecule (C-CAM1): the adhesion and growth suppression are mediated by different domains.
Luo W; Wood CG; Earley K; Hung MC; Lin SH
Oncogene; 1997 Apr; 14(14):1697-704. PubMed ID: 9135071
[TBL] [Abstract][Full Text] [Related]
15. [CEACAM1--a less well-known member of the family of carcinoembryonic antigens].
Muchová L; Vítek L; Jirsa M
Cas Lek Cesk; 2003; 142(5):259-63. PubMed ID: 12920788
[TBL] [Abstract][Full Text] [Related]
16. Conserved residues amino-terminal of cytoplasmic tyrosines contribute to the SHP-1-mediated inhibitory function of killer cell Ig-like receptors.
Burshtyn DN; Lam AS; Weston M; Gupta N; Warmerdam PA; Long EO
J Immunol; 1999 Jan; 162(2):897-902. PubMed ID: 9916713
[TBL] [Abstract][Full Text] [Related]
17. Carcinoembryonic antigen-related cell adhesion molecule 1a-4L suppression of rat hepatocellular carcinomas.
Laurie NA; Comegys MM; Carreiro MP; Brown JF; Flanagan DL; Brilliant KE; Hixson DC
Cancer Res; 2005 Dec; 65(23):11010-7. PubMed ID: 16322250
[TBL] [Abstract][Full Text] [Related]
18. Secreted CEACAM1 splice variants in rat cell lines and in vivo in rat serum.
Budt M; Michely B; Müller MM; Reutter W; Lucka L
Biochem Biophys Res Commun; 2002 Apr; 292(3):749-55. PubMed ID: 11922629
[TBL] [Abstract][Full Text] [Related]
19. Clustering-induced signaling of CEACAM1 in PC12 cells.
Budt M; Cichocka I; Reutter W; Lucka L
Biol Chem; 2002 May; 383(5):803-12. PubMed ID: 12108545
[TBL] [Abstract][Full Text] [Related]
20. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.
Wang L; Lin SH; Wu WG; Kemp BL; Walsh GL; Hong WK; Mao L
Clin Cancer Res; 2000 Aug; 6(8):2988-93. PubMed ID: 10955775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
